vs

Side-by-side financial comparison of ACV Auctions Inc. (ACVA) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.

ACV Auctions Inc. is the larger business by last-quarter revenue ($183.6M vs $151.7M, roughly 1.2× Nutex Health, Inc.). On growth, ACV Auctions Inc. posted the faster year-over-year revenue change (15.1% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $-14.7M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 12.3%).

ACV Auctions Inc. operates a leading digital wholesale vehicle auction platform serving automotive dealers across the U.S. and Canada. It offers end-to-end services including transparent vehicle inspections, secure payment processing, and logistics support, enabling efficient trading of used vehicles between registered wholesale buyers and sellers.

Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.

ACVA vs NUTX — Head-to-Head

Bigger by revenue
ACVA
ACVA
1.2× larger
ACVA
$183.6M
$151.7M
NUTX
Growing faster (revenue YoY)
ACVA
ACVA
+56.3% gap
ACVA
15.1%
-41.1%
NUTX
More free cash flow
NUTX
NUTX
$83.6M more FCF
NUTX
$69.0M
$-14.7M
ACVA
Faster 2-yr revenue CAGR
NUTX
NUTX
Annualised
NUTX
50.0%
12.3%
ACVA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACVA
ACVA
NUTX
NUTX
Revenue
$183.6M
$151.7M
Net Profit
$11.8M
Gross Margin
30.4%
Operating Margin
-9.7%
20.4%
Net Margin
7.8%
Revenue YoY
15.1%
-41.1%
Net Profit YoY
-80.8%
EPS (diluted)
$-0.12
$2.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACVA
ACVA
NUTX
NUTX
Q4 25
$183.6M
$151.7M
Q3 25
$199.6M
$267.8M
Q2 25
$193.7M
$244.0M
Q1 25
$182.7M
$211.8M
Q4 24
$159.5M
$257.6M
Q3 24
$171.3M
$78.8M
Q2 24
$160.6M
$76.1M
Q1 24
$145.7M
$67.5M
Net Profit
ACVA
ACVA
NUTX
NUTX
Q4 25
$11.8M
Q3 25
$-24.5M
$55.4M
Q2 25
$-7.3M
$-17.7M
Q1 25
$-14.8M
$21.2M
Q4 24
$61.6M
Q3 24
$-16.0M
$-8.8M
Q2 24
$-17.1M
$-364.0K
Q1 24
$-20.5M
$-364.0K
Gross Margin
ACVA
ACVA
NUTX
NUTX
Q4 25
30.4%
Q3 25
57.8%
Q2 25
51.2%
Q1 25
55.9%
Q4 24
55.0%
Q3 24
27.8%
Q2 24
29.7%
Q1 24
15.1%
Operating Margin
ACVA
ACVA
NUTX
NUTX
Q4 25
-9.7%
20.4%
Q3 25
-11.9%
48.7%
Q2 25
-3.7%
13.8%
Q1 25
-7.9%
38.1%
Q4 24
-16.2%
44.4%
Q3 24
-10.0%
12.3%
Q2 24
-11.6%
7.0%
Q1 24
-15.5%
2.1%
Net Margin
ACVA
ACVA
NUTX
NUTX
Q4 25
7.8%
Q3 25
-12.3%
20.7%
Q2 25
-3.8%
-7.3%
Q1 25
-8.1%
10.0%
Q4 24
23.9%
Q3 24
-9.4%
-11.2%
Q2 24
-10.6%
-0.5%
Q1 24
-14.1%
-0.5%
EPS (diluted)
ACVA
ACVA
NUTX
NUTX
Q4 25
$-0.12
$2.34
Q3 25
$-0.14
$7.76
Q2 25
$-0.04
$-2.95
Q1 25
$-0.09
$3.33
Q4 24
$-0.15
$11.56
Q3 24
$-0.10
$-1.72
Q2 24
$-0.10
$-0.07
Q1 24
$-0.13
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACVA
ACVA
NUTX
NUTX
Cash + ST InvestmentsLiquidity on hand
$271.5M
$185.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$429.7M
$329.4M
Total Assets
$1.1B
$918.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACVA
ACVA
NUTX
NUTX
Q4 25
$271.5M
$185.6M
Q3 25
$265.3M
$166.0M
Q2 25
$258.4M
$96.7M
Q1 25
$291.9M
$84.7M
Q4 24
$224.1M
$40.6M
Q3 24
$252.5M
$46.9M
Q2 24
$215.0M
$40.8M
Q1 24
$209.8M
$30.0M
Stockholders' Equity
ACVA
ACVA
NUTX
NUTX
Q4 25
$429.7M
$329.4M
Q3 25
$434.4M
$317.2M
Q2 25
$448.8M
$235.3M
Q1 25
$439.6M
$176.9M
Q4 24
$440.0M
$132.4M
Q3 24
$456.2M
$60.4M
Q2 24
$457.6M
$62.7M
Q1 24
$458.3M
$63.0M
Total Assets
ACVA
ACVA
NUTX
NUTX
Q4 25
$1.1B
$918.5M
Q3 25
$1.2B
$964.5M
Q2 25
$1.1B
$841.0M
Q1 25
$1.2B
$761.9M
Q4 24
$984.1M
$655.3M
Q3 24
$1.0B
$438.5M
Q2 24
$1.0B
$422.4M
Q1 24
$1.0B
$404.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACVA
ACVA
NUTX
NUTX
Operating Cash FlowLast quarter
$-12.4M
$70.4M
Free Cash FlowOCF − Capex
$-14.7M
$69.0M
FCF MarginFCF / Revenue
-8.0%
45.5%
Capex IntensityCapex / Revenue
1.2%
0.9%
Cash ConversionOCF / Net Profit
5.95×
TTM Free Cash FlowTrailing 4 quarters
$69.1M
$245.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACVA
ACVA
NUTX
NUTX
Q4 25
$-12.4M
$70.4M
Q3 25
$10.3M
$99.5M
Q2 25
$13.7M
$27.3M
Q1 25
$66.6M
$51.0M
Q4 24
$-3.2M
$54.0K
Q3 24
$21.1M
$6.8M
Q2 24
$4.5M
$13.3M
Q1 24
$43.0M
$3.1M
Free Cash Flow
ACVA
ACVA
NUTX
NUTX
Q4 25
$-14.7M
$69.0M
Q3 25
$7.7M
$99.2M
Q2 25
$10.9M
$26.5M
Q1 25
$65.3M
$50.9M
Q4 24
$-3.9M
$-341.0K
Q3 24
$20.2M
$6.2M
Q2 24
$2.7M
$12.7M
Q1 24
$41.9M
$2.3M
FCF Margin
ACVA
ACVA
NUTX
NUTX
Q4 25
-8.0%
45.5%
Q3 25
3.8%
37.0%
Q2 25
5.6%
10.9%
Q1 25
35.7%
24.0%
Q4 24
-2.5%
-0.1%
Q3 24
11.8%
7.8%
Q2 24
1.7%
16.7%
Q1 24
28.8%
3.4%
Capex Intensity
ACVA
ACVA
NUTX
NUTX
Q4 25
1.2%
0.9%
Q3 25
1.3%
0.1%
Q2 25
1.5%
0.3%
Q1 25
0.7%
0.0%
Q4 24
0.4%
0.2%
Q3 24
0.6%
0.8%
Q2 24
1.1%
0.7%
Q1 24
0.7%
1.1%
Cash Conversion
ACVA
ACVA
NUTX
NUTX
Q4 25
5.95×
Q3 25
1.80×
Q2 25
Q1 25
2.40×
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACVA
ACVA

Auction Marketplace Revenue$77.6M42%
Other Marketplace Revenue$72.4M39%
Customer Assurance$24.1M13%
Data Services Revenue$9.4M5%

NUTX
NUTX

Hospital Division$143.7M95%
Population Health Management Division$8.0M5%

Related Comparisons